Jin, G., Zheng, K., Liu, S., Yi, H., Wei, W., Xu, C., . . . Kang, Y. (2025). In Vivo PK-PD and Drug–Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia. MDPI AG.
Chicago Style (17th ed.) CitationJin, Guanqin, Kewei Zheng, Shihuang Liu, Huan Yi, Wei Wei, Congjian Xu, Xiaoqiang Xiang, and Yu Kang. In Vivo PK-PD and Drug–Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia. MDPI AG, 2025.
MLA (9th ed.) CitationJin, Guanqin, et al. In Vivo PK-PD and Drug–Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia. MDPI AG, 2025.
Warning: These citations may not always be 100% accurate.